Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beswick

Showing results (541-550 of 673) with videos related to

Pageof 68
Sort By:
Arthritis Care & Research|April 30, 2019
Effect of Group-Based Outpatient Physical Therapy on Function After Total Knee Replacement: Results From a Multicenter Randomized Controlled TrialErik Lenguerrand, Neil Artz, Elsa Marques, et al.
Journal of Crohn'S & Colitis|January 28, 2021
Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn's DiseaseCarl Grim, Robert Noble, Gabriela Uribe, et al.
International Journal of Cancer|August 5, 2015
Blockade of MK2 is protective in inflammation-associated colorectal cancer developmentAnita L Ray, Eliseo F Castillo, Katherine T Morris, et al.
International Forum of Allergy & Rhinology|August 9, 2023
Does air pollutant exposure impact disease severity or outcomes in chronic rhinosinusitis?Robert Hagedorn, Benton Tullis, Cassidy Nguyen, et al.
Internal Medicine Journal|November 6, 2014
Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of responseS Ghaly, S Costello, L Beswick, et al.
Internal Medicine Journal|March 4, 2015
Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patientsS P Costello, S Ghaly, L Beswick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 30, 2014
TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cellsEllen J Beswick, Jameel R Johnson, Jamal I Saada, et al.
The Science of the Total Environment|June 17, 2021
Review of biological risks associated with the collection of municipal wastesAnne Mette Madsen, Monika Raulf, Philippe Duquenne, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
No Evidence for BRAF as a melanoma/nevus susceptibility geneSharon Jackson, Mark Harland, Faye Turner, et al.
International Forum of Allergy & Rhinology|March 2, 2025
Elexacaftor-Tezacaftor-Ivacaftor Improves Sinonasal Outcomes in Young Children With Cystic FibrosisAmanda L Stapleton, Adam Kimple, Jennifer L Goralski, et al.
Pageof 68

Showing results (541-550 of 673) with videos related to

Sort By:
Pageof 68
Arthritis Care & Research|April 30, 2019
Effect of Group-Based Outpatient Physical Therapy on Function After Total Knee Replacement: Results From a Multicenter Randomized Controlled TrialErik Lenguerrand, Neil Artz, Elsa Marques, et al.
Journal of Crohn'S & Colitis|January 28, 2021
Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn's DiseaseCarl Grim, Robert Noble, Gabriela Uribe, et al.
International Journal of Cancer|August 5, 2015
Blockade of MK2 is protective in inflammation-associated colorectal cancer developmentAnita L Ray, Eliseo F Castillo, Katherine T Morris, et al.
International Forum of Allergy & Rhinology|August 9, 2023
Does air pollutant exposure impact disease severity or outcomes in chronic rhinosinusitis?Robert Hagedorn, Benton Tullis, Cassidy Nguyen, et al.
Internal Medicine Journal|November 6, 2014
Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of responseS Ghaly, S Costello, L Beswick, et al.
Internal Medicine Journal|March 4, 2015
Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patientsS P Costello, S Ghaly, L Beswick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 30, 2014
TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cellsEllen J Beswick, Jameel R Johnson, Jamal I Saada, et al.
The Science of the Total Environment|June 17, 2021
Review of biological risks associated with the collection of municipal wastesAnne Mette Madsen, Monika Raulf, Philippe Duquenne, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
No Evidence for BRAF as a melanoma/nevus susceptibility geneSharon Jackson, Mark Harland, Faye Turner, et al.
International Forum of Allergy & Rhinology|March 2, 2025
Elexacaftor-Tezacaftor-Ivacaftor Improves Sinonasal Outcomes in Young Children With Cystic FibrosisAmanda L Stapleton, Adam Kimple, Jennifer L Goralski, et al.
Pageof 68